Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes

OBJECTIVE: To assess the efficacy and safety of 32 mg naltrexone sustained-release (SR)/360 mg bupropion SR (NB) in overweight/obese individuals with type 2 diabetes with or without background oral antidiabetes drugs. RESEARCH DESIGN AND METHODS: This was a 56-week, double-blind, placebo-controlled...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hollander, Priscilla, Gupta, Alok K., Plodkowski, Raymond, Greenway, Frank, Bays, Harold, Burns, Colleen, Klassen, Preston, Fujioka, Ken
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2013
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3836105/
https://ncbi.nlm.nih.gov/pubmed/24144653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc13-0234
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados